Speaker Details

Nada Elbuluk, MD, FAAD

Nada Elbuluk, MD, FAAD

SESSIONS

F021 Where Do We Stand? The Pathogenesis and Treatment of Melasma
Mar 27, 2026 1:00 PM - 3:00 PM Bluebird 1A
U028 Pigmentary Potpourri: How to Evaluate, Diagnose, and Treat Pigmentary Conditions
Mar 28, 2026 7:30 AM - 8:30 AM Four Seasons 4
S038 Vitiligo
Mar 28, 2026 1:00 PM - 4:00 PM Mile High 2B
S045 Skin of Color
Mar 29, 2026 1:00 PM - 4:00 PM Mile High 2B

DISCLOSURES

AbbVie – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Avita Medical – Consultant (1099 relationship)(Fees); Beiersdorf – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker(Fees); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Dior – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Advisory Board(Fees); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees), Consultant(Fees); Janssen Biotech – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Kao USA – Consultant (1099 relationship)(Fees); Kenvue – Advisory Board(Fees); L'Oreal USA Inc. – Advisory Board(Fees); McGraw-Hill Companies – Advisory Board(Fees), Other(Other Financial Benefit); Medscape – Speaker(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Teva Pharmaceuticals USA – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Advisory Board(Fees); VisualDx – Consultant(Fees), Consultant(Stock Options); Women's Dermatologic Society – Board of Directors(No Compensation Received);